{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:46:36Z","timestamp":1769697996357,"version":"3.49.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11904-025-00759-8","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:54:40Z","timestamp":1761548080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human Immunodeficiency Virus and Hepatitis B Virus Co-infection in Pregnancy: A Review"],"prefix":"10.1007","volume":"22","author":[{"given":"Alison","family":"Craik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Hamlyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"759_CR1","unstructured":"World Health Organisation. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030. Geneva. 2022 [cited 2024 Dec 20]. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/360348\/9789240053779-eng.pdf?sequence=1&isAllowed=y"},{"issue":"1","key":"759_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/jac\/dkp414","volume":"1","author":"K Lacombe","year":"2010","unstructured":"Lacombe K, Bottero J, Lemoine M, Boyd A, Girard PM. HIV\/hepatitis B virus co-infection: current challenges and new strategies. J Antimicrob Chemother. 2010;1(1):10\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"18","key":"759_CR3","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1097\/QAD.0000000000001646","volume":"28","author":"AC Thornton","year":"2017","unstructured":"Thornton AC, Jose S, Bhagani S, Chadwick D, Dunn D, Gilson R, et al. Hepatitis B, hepatitis C, and mortality among HIV-positive individuals. AIDS Nov. 2017;28(18):2525\u201332.","journal-title":"AIDS Nov"},{"issue":"1","key":"759_CR4","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/S2352-3018(15)00207-6","volume":"3","author":"COO Wedi","year":"2016","unstructured":"Wedi COO, Kirtley S, Hopewell S, Corrigan R, Kennedy SH, Hemelaar J. Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis. Lancet HIV. 2016;3(1):e33-48.","journal-title":"Lancet HIV"},{"issue":"9","key":"759_CR5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/INF.0000000000003174","volume":"7","author":"VJ Tukei","year":"2021","unstructured":"Tukei VJ, Hoffman HJ, Greenberg L, Thabelo R, Nchephe M, Mots\u2019oane T, et al. Adverse pregnancy outcomes among HIV-positive women in the era of universal antiretroviral therapy remain elevated compared with HIV-negative women. Pediatr Infect Disease J Sep. 2021;7(9):821\u20136.","journal-title":"Pediatr Infect Disease J Sep"},{"issue":"4","key":"759_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJMra2212877","volume":"26","author":"AC Eke","year":"2023","unstructured":"Eke AC, Mirochnick M, Lockman S. Antiretroviral therapy and adverse pregnancy outcomes in people living with HIV. New Engl J Med. 2023;26(4):344\u201356.","journal-title":"New Engl J Med"},{"issue":"1","key":"759_CR7","first-page":"1","volume":"16","author":"AZ Haniah","year":"2024","unstructured":"Haniah AZ, Budihastuti UR, Pamungkasari EP. Meta-Analysis the effect of pregnancy with hepatitis B on preterm birth and gestational diabetes mellitus. J Maternal Child Health Jan. 2024;16(1):1\u201313.","journal-title":"J Maternal Child Health Jan"},{"issue":"1","key":"759_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12985-023-02182-0","volume":"14","author":"M Afraie","year":"2023","unstructured":"Afraie M, Moradi G, Zamani K, Azami M, Moradi Y. The effect of hepatitis B virus on the risk of pregnancy outcomes: a systematic review and meta-analysis of cohort studies. Virol J. 2023;14(1):213.","journal-title":"Virol J"},{"issue":"31","key":"759_CR9","first-page":"e21416","volume":"31","author":"R Jiang","year":"2020","unstructured":"Jiang R, Wang T, Yao Y, Zhou F, Huang X. Hepatitis B infection and intrahepatic cholestasis of pregnancy. Med Jul. 2020;31(31):e21416.","journal-title":"Med Jul"},{"key":"759_CR10","doi-asserted-by":"crossref","unstructured":"Matovu Kiweewa F, Tierney C, Butler K, Peters MG, Vhembo T, Moodley D et al. Impact of antiretroviral regimen on pregnancy and infant outcomes in women with HIV\/ HBV coinfection. J Acquir Immune Defic Syndr Sep 1 2022;91(1):79\u201384.","DOI":"10.1097\/QAI.0000000000003022"},{"issue":"11","key":"759_CR11","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1136\/gutjnl-2014-308211","volume":"64","author":"M Giles","year":"2015","unstructured":"Giles M, Visvanathan K, Lewin S, Bowden S, Locarnini S, Spelman T, et al. Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B. Gut. 2015;64(11):1810\u20135.","journal-title":"Gut"},{"key":"759_CR12","first-page":"13","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Song A, Lin X, Lu J, Zheng S, Ma L, et al. Clinical characteristics of hepatitis flares during pregnancy and postpartum in Chinese chronic hepatitis B virus carriers\u2014a prospective cohort study of 417 cases. Front Immunol Oct. 2022;13:13.","journal-title":"Front Immunol Oct"},{"key":"759_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002980","author":"D Bhattacharya","year":"2021","unstructured":"Bhattacharya D, Guo R, Tseng CH, Emel L, Sun R, Chiu SH, et al. Maternal HBV viremia and association with adverse infant outcomes in women living with HIV and HBV. Pediatr Infect Dis J. 2021;40(2):e56\u2013e61.\u00a0https:\/\/doi.org\/10.1097\/INF.0000000000002980.","journal-title":"Pediatr Infect Dis J"},{"key":"759_CR14","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jama.2023.5076","volume":"329","author":"AC Eke","year":"2023","unstructured":"Eke AC, Lockman S, Mofenson LM, American Medical Association. Antiretroviral treatment of HIV\/AIDS during pregnancy. JAMA. 2023;329:1308\u20139.","journal-title":"JAMA"},{"key":"759_CR15","unstructured":"World Health Organization. Global hepatitis report 2024: Action for access in low-and middle-income countries [Internet]. Geneva. 2024. Available from: https:\/\/iris.who.int\/"},{"key":"759_CR16","unstructured":"UNAIDS. Fact sheet 2024 - Latest global and regional HIV statistics on the status of the AIDS epidemic [Internet]. 2024 [cited 2024 Nov 24]. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf"},{"issue":"3","key":"759_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/jvh.13217","volume":"1","author":"L Platt","year":"2020","unstructured":"Platt L, French CE, McGowan CR, Sabin K, Gower E, Trickey A, et al. Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis. J Viral Hepat Mar. 2020;1(3):294\u2013315.","journal-title":"J Viral Hepat Mar"},{"key":"759_CR18","doi-asserted-by":"crossref","unstructured":"B\u00e9guelin C, Moradpour D, Sahli R, Suter-Riniker F, L\u00fcthi A, Cavassini M et al. Hepatitis delta-associated mortality in HIV\/HBV-coinfected patients. J Hepatol Feb 2016;66(2):297\u2013303 .","DOI":"10.1016\/j.jhep.2016.10.007"},{"key":"759_CR19","doi-asserted-by":"crossref","unstructured":"Kafeero HM, Ndagire D, Ocama P, Walusansa A, Sendagire H. Sero-prevalence of human immunodeficiency virus\u2013hepatitis B virus (HIV\u2013HBV) co-infection among pregnant women attending antenatal care (ANC) in sub-Saharan Africa (SSA) and the associated risk factors: a systematic review and meta-analysis. Virol J Dec 1 2020;17(1):170.","DOI":"10.1186\/s12985-020-01443-6"},{"key":"759_CR20","doi-asserted-by":"crossref","unstructured":"Wu S, Wang J, Guo Q, Lan H, Sun Y, Ren M, et al. Prevalence of human immunodeficiency virus, syphilis, and hepatitis B and C virus infections in pregnant women: a systematic review and meta-analysis. Clinical Microbiology and Infection. Elsevier B.V. 2023;29:1000\u20137.","DOI":"10.1016\/j.cmi.2023.03.002"},{"key":"759_CR21","unstructured":"National Institutes of Health, Centers for Disease Control and Prevention, Association HIVM, and Infectious Diseases Society of America. 2024 [cited 2024 Nov 27]. Panel on Guidelines for the PreventionTreatment of Opportunistic Infections in AdultsAdolescents with HIV. Guidelines for the PreventionTreatment of Opportunistic Infections in AdultsAdolescents with HIV. Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-opportunistic-infection"},{"key":"759_CR22","doi-asserted-by":"crossref","unstructured":"Geretti AM, Brook G, Cameron C, Chadwick D, French N, Heyderman R, et al. British HIV association guidelines on the use of vaccines in HIV-positive adults 2015. HIV Med. Aug 2016;17:S3:s2\u2013s81 .","DOI":"10.1111\/hiv.12424"},{"key":"759_CR23","unstructured":"European AIDS. Clinical Society. EACS European AIDS Clinical Society Guidelines 12.0. 2023 Oct."},{"key":"759_CR24","unstructured":"World Health Organization. Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. Geneva; 2022."},{"issue":"41","key":"759_CR25","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.1016\/j.vaccine.2018.08.074","volume":"1","author":"HC Groom","year":"2018","unstructured":"Groom HC, Irving SA, Koppolu P, Smith N, Vazquez-Benitez G, Kharbanda EO, et al. Uptake and safety of hepatitis B vaccination during pregnancy: A vaccine safety datalink study. Vaccine Oct. 2018;1(41):6111\u20136.","journal-title":"Vaccine Oct"},{"issue":"48","key":"759_CR26","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.15585\/mmwr.mm7348a3","volume":"5","author":"AL Sandul","year":"2024","unstructured":"Sandul AL, Rapposelli K, Nyendak M, Kim M. Updated recommendation for universal hepatitis B vaccination in adults aged 19\u201359 years \u2014 United States, 2024. MMWR Morb Mortal Wkly Rep. 2024;5(48):1106.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"759_CR27","unstructured":"UK Health Security Agency. Chapter 17 Hepatitis A. In: The Green Book- Immunisation against infectious disease. 2024."},{"key":"759_CR28","unstructured":"British Viral Hepatitis Group- Maternal and Paediatric Subgroup. Guideline for the management of Hepatitis B in pregnancy and the exposed infant. 2021 Mar [cited 2024 Dec 10]. Available from: https:\/\/www.basl.org.uk\/uploads\/BVHG%20Perinatal%20HBV%203.3.21.pdf"},{"issue":"6","key":"759_CR29","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/00365521.2019.1629007","volume":"54","author":"M Stenberg Ribeiro","year":"2019","unstructured":"Stenberg Ribeiro M, Hagstr\u00f6m H, Stal P, Ajne G. Transient liver elastography in normal pregnancy \u2013 a longitudinal cohort study. Scand J Gastroenterol. 2019;54(6):761\u20135.","journal-title":"Scand J Gastroenterol"},{"issue":"38","key":"759_CR30","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.3748\/wjg.v24.i38.4393","volume":"14","author":"FJ Ammon","year":"2018","unstructured":"Ammon FJ, Kohlhaas A, Elshaarawy O, Mueller J, Bruckner T, Sohn C, et al. Liver stiffness reversibly increases during pregnancy and independently predicts preeclampsia. World J Gastroenterol Oct. 2018;14(38):4393\u2013402.","journal-title":"World J Gastroenterol Oct"},{"key":"759_CR31","unstructured":"Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission. Department of Health and Human Services. 2024 [cited 2024 Dec 10]. Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/perinatal"},{"key":"759_CR32","unstructured":"Byrne L, Bamford A, Bradshaw D, Clarke E, De Oliveira A, Macleod K et al. BHIVA guidelines on the management of HIV in pregnancy and the postpartum period 2024 [Internet]. 2024 Dec [cited 2025 Jan 28]. Available from: https:\/\/bhiva.org\/wp-content\/uploads\/2024\/12\/BHIVA-pregnancy-guidelines-for-public-consultation.pdf"},{"key":"759_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1155\/2014\/350179","volume":"28","author":"MS Chang","year":"2014","unstructured":"Chang MS, Gavini S, Andrade PharmD PC, McNabb-Baltar J, Chang M, Gavini S, et al. Caesarean section to prevent transmission of hepatitis B: a meta-analysis. Can J Gastroenterol Hepatol Sep. 2014;28:439.","journal-title":"Can J Gastroenterol Hepatol Sep"},{"issue":"5","key":"759_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/QAI.0000000000001618","volume":"15","author":"V Benhammou","year":"2018","unstructured":"Benhammou V, Tubiana R, Matheron S, Sellier P, Mandelbrot L, Chenadec J, et al. HBV or HCV coinfection in HIV-1-Infected pregnant women in france: prevalence and pregnancy outcomes. J Acquir Immune Defic Syndr (1988) Apr. 2018;15(5):439\u201350.","journal-title":"J Acquir Immune Defic Syndr (1988) Apr"},{"issue":"2","key":"759_CR35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/15284336.2016.1276312","volume":"4","author":"M Floridia","year":"2017","unstructured":"Floridia M, Masuelli G, Tamburrini E, Spinillo A, Simonazzi G, Guaraldi G, et al. HBV coinfection is associated with reduced CD4 response to antiretroviral treatment in pregnancy. HIV Clin Trials Mar. 2017;4(2):54\u20139.","journal-title":"HIV Clin Trials Mar"},{"issue":"2","key":"759_CR36","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/hep.27034","volume":"60","author":"H Zhang","year":"2014","unstructured":"Zhang H, Pan CQ, Pang Q, Tian R, Yan M, Liu X. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology. 2014;60(2):468\u201376.","journal-title":"Hepatology"},{"issue":"1","key":"759_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1468-1293.2008.00646.x","volume":"10","author":"C Bellini","year":"2009","unstructured":"Bellini C, Keiser O, Chave JP, Evison JM, Fehr J, Kaiser L, et al. Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV cohort study. HIV Med. 2009;10(1):12\u20138.","journal-title":"HIV Med"},{"issue":"10","key":"759_CR38","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/apt.12726","volume":"25","author":"V Nguyen","year":"2014","unstructured":"Nguyen V, Tan PK, Greenup A-J, Glass A, Davison S, Samarasinghe D, et al. Anti\u2010viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post\u2010partum flare. Aliment Pharmacol Ther May. 2014;25(10):1225\u201334.","journal-title":"Aliment Pharmacol Ther May"},{"issue":"16","key":"759_CR39","first-page":"1","volume":"8","author":"EE Mast","year":"2006","unstructured":"Mast EE, Weinbaum CM, Fiore AE, Alter M, Bell BP, Finelli L, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the united states: recommendations of the advisory committee on immunization practices (ACIP) part II: immunization of adults. MMWR recommendations and reports: morbidity and mortality weekly report. Dec. 2006;8(16):1\u201333.","journal-title":"Dec"},{"issue":"1","key":"759_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S1473-3099(20)30586-7","volume":"21","author":"AL Funk","year":"2021","unstructured":"Funk AL, Lu Y, Yoshida K, Zhao T, Boucheron P, van Holten J, et al. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(1):70\u201384.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"759_CR41","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/hep.28302","volume":"13","author":"RS Brown","year":"2016","unstructured":"Brown RS, McMahon BJ, Lok ASF, Wong JB, Ahmed AT, Mouchli MA, et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis. Hepatol Jan. 2016;13(1):319\u201333.","journal-title":"Hepatol Jan"},{"issue":"24","key":"759_CR42","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","volume":"16","author":"CQ Pan","year":"2016","unstructured":"Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. New Engl J Med Jun. 2016;16(24):2324\u201334.","journal-title":"New Engl J Med Jun"},{"issue":"3","key":"759_CR43","first-page":"329","volume":"38","author":"D Bhattacharya","year":"2024","unstructured":"Bhattacharya D, Guo R, Tseng CH, Emel L, Sun R, Zhang T, et al. hao, Hepatitis B virus clinical and virologic characteristics in an HIV perinatal transmission study in sub-Saharan Africa. AIDS.\u00a0Mar 1. 2024;38(3):329\u201337.","journal-title":"AIDS.\u00a0Mar 1"},{"issue":"1","key":"759_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1473-3099(20)30593-4","volume":"21","author":"P Boucheron","year":"2021","unstructured":"Boucheron P, Lu Y, Yoshida K, Zhao T, Funk AL, Lunel-Fabiani F, et al. Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(1):85\u201396.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"759_CR45","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/infdis\/jiw439","volume":"1","author":"L Wang","year":"2016","unstructured":"Wang L, Wiener J, Bulterys M, Wei X, Chen L, Liu W, et al. Hepatitis B virus (HBV) load response to 2 antiviral Regimens, Tenofovir\/Lamivudine and Lamivudine, in HIV\/ HBV-Coinfected pregnant women in Guangxi, china: the Tenofovir in pregnancy (TiP) study. J Infect Dis Dec. 2016;1(11):1695\u20139.","journal-title":"J Infect Dis Dec"},{"key":"759_CR46","unstructured":"United States Center for Disease Control. https:\/\/www.cdc.gov\/hepatitis-b\/hcp\/prenatal-provider-overview\/index.html. 2024. Clinical Overview of Perinatal Hepatitis B."},{"issue":"1","key":"759_CR47","first-page":"1","volume":"12","author":"S Schillie","year":"2018","unstructured":"Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, et al. Prevention of hepatitis B virus infection in the united states: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep Jan. 2018;12(1):1\u201331.","journal-title":"MMWR Recomm Rep Jan"},{"issue":"1","key":"759_CR48","first-page":"1","volume":"8","author":"G Brook","year":"2010","unstructured":"Brook G, Main J, Nelson M, Bhagani S, Wilkins E, Leen C, et al. British HIV association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010. HIV Med Jan. 2010;8(1):1\u201330.","journal-title":"HIV Med Jan"},{"key":"759_CR49","unstructured":"Electronic Medicines Compendium. https:\/\/www.medicines.org.uk\/emc\/product\/9873\/smpc#about-medicine. 2024 [cited 2024 Dec 10]. Entecavir 0.5\u00a0mg film-coated tablets - Summary of Product Characteristics (SmPC). Available from: https:\/\/www.medicines.org.uk\/emc\/product\/9873\/smpc#about-medicine"},{"key":"759_CR50","unstructured":"Joint Formulary Committee. British National Formulary (online) London BMJ and Pharmaceutical Press. 2024 [cited 2024 Dec 10]. Adefovir dipivoxil. Available from: https:\/\/bnf.nice.org.uk\/drugs\/adefovir-dipivoxil\/"},{"key":"759_CR51","unstructured":"Electronic Medicines Compendium. Sebivo 600\u00a0mg film-coated tablets - Summary of Product Characteristics (SmPC) [Internet]. 2024 [cited 2024 Dec 10]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/335\/smpc"},{"key":"759_CR52","doi-asserted-by":"crossref","unstructured":"Gandhi RT, Landovitz RJ, Sax PE, Smith DM, Springer SA, G\u00fcnthard HF et al. Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the international antiviral Society\u2013USA panel. JAMA. 2025.","DOI":"10.1001\/jama.2024.24543"},{"key":"759_CR53","unstructured":"Morrisville N.\u00a02024 [cited 2024 Dec 10]. Antiretroviral Pregnancy Registry Interim Report for 1 January 1989 through 31 January 2024. Available from: https:\/\/www.apregistry.com\/forms\/interim_report.pdf"},{"issue":"4","key":"759_CR54","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/17425255.2020.1738384","volume":"2","author":"AC Eke","year":"2020","unstructured":"Eke AC, Brooks KM, Gebreyohannes RD, Sheffield JS, Dooley KE, Mirochnick M. Tenofovir Alafenamide use in pregnant and lactating women living with HIV. Expert Opin Drug Metab Toxicol Apr. 2020;2(4):333\u201342.","journal-title":"Expert Opin Drug Metab Toxicol Apr"},{"issue":"10","key":"759_CR55","doi-asserted-by":"publisher","first-page":"e640","DOI":"10.1016\/S2352-3018(23)00151-0","volume":"10","author":"A Avihingsanon","year":"2023","unstructured":"Avihingsanon A, Lu H, Leong CL, Hung CC, Koenig E, Kiertiburanakul S, et al. Bictegravir, emtricitabine, and Tenofovir Alafenamide versus dolutegravir, emtricitabine, and Tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial. Lancet HIV Oct. 2023;10(10):e640\u201352.","journal-title":"Lancet HIV Oct"},{"issue":"9","key":"759_CR56","doi-asserted-by":"publisher","first-page":"e3324","DOI":"10.1093\/cid\/ciaa1939","volume":"2","author":"QL Zeng","year":"2021","unstructured":"Zeng QL, Yu ZJ, Ji F, Li GM, Zhang GF, Xu JH, et al. Tenofovir Alafenamide to prevent perinatal hepatitis B transmission: A Multicenter, Prospective, observational study. Clin Infect Dis Nov. 2021;2(9):e3324\u201332.","journal-title":"Clin Infect Dis Nov"},{"issue":"1","key":"759_CR57","first-page":"6","volume":"4","author":"MA Thimm","year":"2022","unstructured":"Thimm MA, Livingston A, Ramroop R, Eke AC. Pregnancy outcomes in pregnant women with HIV on Tenofovir disoproxil fumarate (TDF) compared to Tenofovir Alafenamide (TAF). J AIDS HIV Treat. 2022;4(1):6\u201313.","journal-title":"J AIDS HIV Treat"},{"issue":"2","key":"759_CR58","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"P Lampertico","year":"2017","unstructured":"Lampertico P, Agarwal K, Berg T, Buti M, Janssen HLA, Papatheodoridis G, et al. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398.","journal-title":"J Hepatol"},{"key":"759_CR59","unstructured":"Zash R, Holmes L, Diseko M, Jacobson D, Mayondi G, Mabuta J et al. Update on neural tube defects with antiretroviral exposure in the Tsepamo Study, Botswana. In 2022 [cited 2024 Dec 10]. Available from: https:\/\/programme.aids2022.org\/Abstract\/Abstract\/?abstractid=12759"},{"issue":"9","key":"759_CR60","doi-asserted-by":"publisher","first-page":"e588","DOI":"10.1016\/S2352-3018(23)00108-X","volume":"10","author":"AP Kourtis","year":"2023","unstructured":"Kourtis AP, Zhu W, Lampe MA, Huang YLA, Hoover KW. Dolutegravir and pregnancy outcomes including neural tube defects in the USA during 2008\u201320: a National cohort study. Lancet HIV. 2023;10(9):e588-96.","journal-title":"Lancet HIV"},{"issue":"4","key":"759_CR61","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/hep.22462","volume":"48","author":"GV Matthews","year":"2008","unstructured":"Matthews GV, Avihingsanon A, Lewin SR, Amin J, Rerknimitr R, Petcharapirat P, et al. A randomized trial of combination hepatitis B therapy in HIV\/HBV coinfected antiretroviral na\u00efve individuals in Thailand. Hepatology. 2008;48(4):1062\u20139.","journal-title":"Hepatology"},{"issue":"3","key":"759_CR62","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/AOG.0000000000005302","volume":"142","author":"D Bhattacharya","year":"2023","unstructured":"Bhattacharya D, Tierney C, Butler K, Kiweewa FM, Moodley D, Govender V, et al. Comparison of antiretroviral therapies in pregnant women living with human immunodeficiency virus and hepatitis B virus. Obstet Gynecol Sep. 2023;142(3):613\u201324.","journal-title":"Obstet Gynecol Sep"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00759-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-025-00759-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-025-00759-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:03:58Z","timestamp":1769609038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-025-00759-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["759"],"URL":"https:\/\/doi.org\/10.1007\/s11904-025-00759-8","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"1 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}